U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Bladder Carcinoma

MedGen UID:
82989
•Concept ID:
C0278827
•
Neoplastic Process
Synonyms: Bladder Cancer, Recurrent; Bladder Carcinoma Recurrent; Recurrent Bladder Cancer; Recurrent Cancer of Bladder; Recurrent Cancer of the Bladder; Recurrent Cancer of the Urinary Bladder; Recurrent Cancer of Urinary Bladder; Recurrent Urinary Bladder Cancer; Relapsed Bladder Cancer; Relapsed Cancer of Bladder; Relapsed Cancer of the Bladder; Relapsed Cancer of the Urinary Bladder; Relapsed Cancer of Urinary Bladder; Relapsed Urinary Bladder Cancer

Definition

The reemergence of bladder carcinoma after a period of remission. [from NCI]

Professional guidelines

PubMed

The potential of radiolabeled EGF-dextran conjugates in the treatment of urinary bladder carcinoma.
Bue P, Márquez M, Malmström PU, Westlin JE, Nilsson S, Holmberg AR
Cancer 1997 Dec 15;80(12 Suppl):2385-9. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2385::aid-cncr8>3.3.co;2-y. PMID: 9406687
Interferon-gamma in the treatment of superficial and recurrent bladder carcinoma. Phase one study.
Fontana G, Caccia P, Alladio F, Laudi M, Pigato M, Sesia G, Forni G, Giovarelli M
Prog Clin Biol Res 1989;303:479-80. PMID: 2506557
Current status of transcatheter management of neoplasms.
Chuang VP, Wallace S
Cardiovasc Intervent Radiol 1980;3(4):256-67. doi: 10.1007/BF02552737. PMID: 7459917

Recent clinical studies

Etiology

A New Prognostic Instrument Specifically Designed for Patients Irradiated for Recurrent Carcinoma of the Bladder.
Manig L, Janssen S, Schild SE, Rades D
In Vivo 2017 May-Jun;31(3):435-438. doi: 10.21873/invivo.11079. PMID: 28438875Free PMC Article
Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.
Alongi P, Caobelli F, Gentile R, Stefano A, Russo G, Albano D, Baldari S, Gilardi MC, Midiri M
Eur J Nucl Med Mol Imaging 2017 Feb;44(2):224-233. Epub 2016 Aug 26 doi: 10.1007/s00259-016-3500-8. PMID: 27565154
Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.
Nisman B, Barak V, Shapiro A, Golijanin D, Peretz T, Pode D
Cancer 2002 Jun 1;94(11):2914-22. doi: 10.1002/cncr.10565. PMID: 12115379
Management of superficial transitional cell carcinoma in the intramural ureter: what to do?
Palou J, Salvador J, Millán F, Collado A, Algaba F, Vicente J
J Urol 2000 Mar;163(3):744-7. PMID: 10687968
Intravesical epirubicin with and without verapamil for the prophylaxis of superficial bladder tumours.
Lukkarinen O, Paul C, Hellström P, Kontturi M, Nurmi M, Puntala P, Ottelin J, Tammela T, Tidefeldt U
Scand J Urol Nephrol 1991;25(1):25-8. doi: 10.3109/00365599109024524. PMID: 2047768

Diagnosis

A New Prognostic Instrument Specifically Designed for Patients Irradiated for Recurrent Carcinoma of the Bladder.
Manig L, Janssen S, Schild SE, Rades D
In Vivo 2017 May-Jun;31(3):435-438. doi: 10.21873/invivo.11079. PMID: 28438875Free PMC Article
Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.
Alongi P, Caobelli F, Gentile R, Stefano A, Russo G, Albano D, Baldari S, Gilardi MC, Midiri M
Eur J Nucl Med Mol Imaging 2017 Feb;44(2):224-233. Epub 2016 Aug 26 doi: 10.1007/s00259-016-3500-8. PMID: 27565154
Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.
Nisman B, Barak V, Shapiro A, Golijanin D, Peretz T, Pode D
Cancer 2002 Jun 1;94(11):2914-22. doi: 10.1002/cncr.10565. PMID: 12115379
Management of superficial transitional cell carcinoma in the intramural ureter: what to do?
Palou J, Salvador J, Millán F, Collado A, Algaba F, Vicente J
J Urol 2000 Mar;163(3):744-7. PMID: 10687968
Image analysis combined with visual cytology in the early detection of recurrent bladder carcinoma.
Richman AM, Mayne ST, Jekel JF, Albertsen P
Cancer 1998 May 1;82(9):1738-48. doi: 10.1002/(sici)1097-0142(19980501)82:9<1749::aid-cncr22>3.0.co;2-3. PMID: 9576297

Therapy

Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.
Järvinen R, Kaasinen E, Sankila A, Rintala E; FinnBladder Group
Eur Urol 2009 Aug;56(2):260-5. Epub 2009 Apr 16 doi: 10.1016/j.eururo.2009.04.009. PMID: 19395154
Intravesical epirubicin with and without verapamil for the prophylaxis of superficial bladder tumours.
Lukkarinen O, Paul C, Hellström P, Kontturi M, Nurmi M, Puntala P, Ottelin J, Tammela T, Tidefeldt U
Scand J Urol Nephrol 1991;25(1):25-8. doi: 10.3109/00365599109024524. PMID: 2047768
Current status of transcatheter management of neoplasms.
Chuang VP, Wallace S
Cardiovasc Intervent Radiol 1980;3(4):256-67. doi: 10.1007/BF02552737. PMID: 7459917
Chemotherapy in bladder carcinoma.
Edsmyr F, Andersson L
Urol Res 1978;6(4):263-4. doi: 10.1007/BF00262632. PMID: 84427
The chemotherapy of advanced bladder carcinoma.
deKernion JB
Cancer Res 1977 Aug;37(8 Pt 2):2771-4. PMID: 326391

Prognosis

A New Prognostic Instrument Specifically Designed for Patients Irradiated for Recurrent Carcinoma of the Bladder.
Manig L, Janssen S, Schild SE, Rades D
In Vivo 2017 May-Jun;31(3):435-438. doi: 10.21873/invivo.11079. PMID: 28438875Free PMC Article
Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.
Alongi P, Caobelli F, Gentile R, Stefano A, Russo G, Albano D, Baldari S, Gilardi MC, Midiri M
Eur J Nucl Med Mol Imaging 2017 Feb;44(2):224-233. Epub 2016 Aug 26 doi: 10.1007/s00259-016-3500-8. PMID: 27565154
Combination of cytologic evaluation and quantitative digital cytometry is reliable in detecting recurrent disease in patients with urinary diversions.
Caraway NP, Khanna A, Payne L, Kamat AM, Katz RL
Cancer 2007 Oct 25;111(5):323-9. doi: 10.1002/cncr.22950. PMID: 17721991
Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings.
Yoder BJ, Skacel M, Hedgepeth R, Babineau D, Ulchaker JC, Liou LS, Brainard JA, Biscotti CV, Jones JS, Tubbs RR
Am J Clin Pathol 2007 Feb;127(2):295-301. doi: 10.1309/ADJL7E810U1H42BJ. PMID: 17210520
Management of superficial transitional cell carcinoma in the intramural ureter: what to do?
Palou J, Salvador J, Millán F, Collado A, Algaba F, Vicente J
J Urol 2000 Mar;163(3):744-7. PMID: 10687968

Clinical prediction guides

A New Prognostic Instrument Specifically Designed for Patients Irradiated for Recurrent Carcinoma of the Bladder.
Manig L, Janssen S, Schild SE, Rades D
In Vivo 2017 May-Jun;31(3):435-438. doi: 10.21873/invivo.11079. PMID: 28438875Free PMC Article
Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.
Alongi P, Caobelli F, Gentile R, Stefano A, Russo G, Albano D, Baldari S, Gilardi MC, Midiri M
Eur J Nucl Med Mol Imaging 2017 Feb;44(2):224-233. Epub 2016 Aug 26 doi: 10.1007/s00259-016-3500-8. PMID: 27565154
Image analysis combined with visual cytology in the early detection of recurrent bladder carcinoma.
Richman AM, Mayne ST, Jekel JF, Albertsen P
Cancer 1998 May 1;82(9):1738-48. doi: 10.1002/(sici)1097-0142(19980501)82:9<1749::aid-cncr22>3.0.co;2-3. PMID: 9576297
Adjuvant doxorubicin hydrochloride and radiation in stage D bladder cancer: a preliminary report.
Schaeffer AJ, Grayhack JT, Merrill JM, Kies MS, Bulkley GJ, Shetty RM, Chmiel JS
J Urol 1984 Jun;131(6):1073-6. doi: 10.1016/s0022-5347(17)50810-1. PMID: 6726904

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...